Category Archives: Biotechnology

Biotechnology simply means to develop or to make useful products with the help of using living systems. Over the years mankind has used biotechnology in several sectors like agriculture, food production and medicine. There are several sectors in which biotechnology can affect severely.

Biotech for human enhancement is the most profitable industry in the 21st century. Careers are influenced by genetic heritage. It is said that by 2020 people will be able to decipher human genome

Which is nothing but the blueprint of our DNA? One of the trends is towards the genetic solutions to the ills. There are several newly discovered drugs will save countless no of lives. These drugs can also eliminate many diseases. A lot of research works have been done on the recent trends for biotechnology. Research output continues to shift to ASIA. The current trends in biotechnology are its association with pharmacy. It is said that within few more years people will be able to turn on or turn off certain genes which can influence on health and performance. People can eliminate unwanted characteristics by using altered genes from their babies. People can also enhance their babies’ capabilities by using the same method. There is different classification of biotechnology having different application of each. Like white or industrial biotechnology helps in the production of chemical base materials and end products. Red biotechnology means development of new medical drugs. Biotechnology is the driving factor behind many applications in medicine. Green or Plant biotechnology is used in production of plants which are renewable recourses. Biotechnology is integrated use of many biological technologies. It also has trends in horticulture. One of the emerging trends in Biotechnology have been observed and noted in recent years. One such trend is the trend in partnering and acquisition of deals. This is applicable to the business perspective towards the delivery and realization of more up to date by products. So basically there are a lot of sectors in which biotechnology can affect. But one of the most suitable choices is pharmaceutical sector. People are focusing more and more now days on the use of biotechnological products. There are a lot of independent biotechnology companies which deals directly with these biotechnological products. Biotechnology is used to develop commercial product also. Biotechnology becomes central priority of the government’s research policy to ensure a high standing of biosciences and to develop newer innovation techniques. At present there are 25 different initiatives to financially support universities, research institutes. They all are working like a chain having same common objectives. There is a healthy competition in between the companies which in turn increases the level of biotechnological products. The key element of this initiative is Biopharma competition. So it depends on the people how they utilize biotechnological products for their better interest.

Biotechnology is a technology which never goes opposite to the nature.

We have to improve the biotechnology with the help of nature. Now a days lots of course are based on Biotechnology in various colleges all over the world. It becomes popular to all the students also.

Source:
http://www.biotechblog.org/entry/top-trends-biotechnology/

Introduction

Genetic disorders are becoming common nowadays due to stressful modern lifestyle. Latest technologies are the added values to create many genetic disorders. To overcome the disorders, Gene therapy is a blessing. In order to compensate abnormal genes and make a good gene, genetic material is introduced into cells. In this way, mutated gene will act as a normal gene. Let us see in detail.

Ways to insert the gene

There are indirect ways need to be followed to make a gene to function as if it is inserted directly does not function. Carrier also called as vector is used to deliver the gene. In the place of vectors, virus play the role as they are getting modified and hence people are not affected with new diseases when it is integrated into the chromosome of the human cell.

The vectors need to get injected to specific tissue in the body or outwardly patient’s cell is removed and exposed to the vector. In either of the ways need to be again returned to the patient. Successful treatment makes proper genes and genetic disorders get solved.

Gene therapy for treating cancer

Cancer is the dangerous disease and there are many ways to cure cancer including surgery, chemotherapy, and radiation. But cancerous cells in due course again spread and hence it is a deadly disease. Gene therapy is the best way discovered nowadays for treating cancer.
Let us see the basic fundamentals of cells. cells include packets of data in genes, created either from DNA or RNA. Sequence is there for DNA and if it is in the order, there will be no problem. But at the same time If there is disorder occurs in portion of the genes either turning or changing the position, cells lost their control and abnormal growth is seen which result in cancerous tumors. It can spread in mouth, breast, lung etc.,

Specialists in Gene therapy analyze the patient’s criticality first and follow the treatment procedures. One way is they replace missing or mutated genes into wholesome genes. Inserting totally new genes for fighting cancer, placing DNA into cancerous cells to undergo chemotherapy and radiation or injecting bad gene to destroy them etc., Mesothelioma type of cancers are not at all responded in formal therapies and hence one need to undergo gene therapy essentially. Need to have consultations with doctors to overcome their deadly disease.

Gene therapy importance

Doctors decide whether gene therapy is suitable by the following approaches. If genetic disorders are from mutations in one or more genes or whether a normal copy of the gene that is available in the patient is enough to fix the problems in the affected cells, then doctors determine that gene therapy will be more helpful rather than going for traditional methods.

Conclusion

Genetic engineering is a vast topic. Latest Science innovations in the field of genetic engineering yields for gene therapy. Doctors and scientists together working to find out whether gene therapy is the best suitable way for treating deadly diseases like cancer and others. Let us salute for the positive force of gene therapy.

Source:
http://www.biotechblog.org/entry/biotechnology-gene-therapy/

Introduction

Genetic disorders are becoming common nowadays due to stressful modern lifestyle. Latest technologies are the added values to create many genetic disorders. To overcome the disorders, Gene therapy is a blessing. In order to compensate abnormal genes and make a good gene, genetic material is introduced into cells. In this way, mutated gene will act as a normal gene. Let us see in detail.

Ways to insert the gene

There are indirect ways need to be followed to make a gene to function as if it is inserted directly does not function. Carrier also called as vector is used to deliver the gene. In the place of vectors, virus play the role as they are getting modified and hence people are not affected with new diseases when it is integrated into the chromosome of the human cell.

The vectors need to get injected to specific tissue in the body or outwardly patient’s cell is removed and exposed to the vector. In either of the ways need to be again returned to the patient. Successful treatment makes proper genes and genetic disorders get solved.

Gene therapy for treating cancer

Cancer is the dangerous disease and there are many ways to cure cancer including surgery, chemotherapy, and radiation. But cancerous cells in due course again spread and hence it is a deadly disease. Gene therapy is the best way discovered nowadays for treating cancer.
Let us see the basic fundamentals of cells. cells include packets of data in genes, created either from DNA or RNA. Sequence is there for DNA and if it is in the order, there will be no problem. But at the same time If there is disorder occurs in portion of the genes either turning or changing the position, cells lost their control and abnormal growth is seen which result in cancerous tumors. It can spread in mouth, breast, lung etc.,

Specialists in Gene therapy analyze the patient’s criticality first and follow the treatment procedures. One way is they replace missing or mutated genes into wholesome genes. Inserting totally new genes for fighting cancer, placing DNA into cancerous cells to undergo chemotherapy and radiation or injecting bad gene to destroy them etc., Mesothelioma type of cancers are not at all responded in formal therapies and hence one need to undergo gene therapy essentially. Need to have consultations with doctors to overcome their deadly disease.

Gene therapy importance

Doctors decide whether gene therapy is suitable by the following approaches. If genetic disorders are from mutations in one or more genes or whether a normal copy of the gene that is available in the patient is enough to fix the problems in the affected cells, then doctors determine that gene therapy will be more helpful rather than going for traditional methods.

Conclusion

Genetic engineering is a vast topic. Latest Science innovations in the field of genetic engineering yields for gene therapy. Doctors and scientists together working to find out whether gene therapy is the best suitable way for treating deadly diseases like cancer and others. Let us salute for the positive force of gene therapy.

Source:
http://www.biotechblog.org/entry/biotechnology-gene-therapy/

Life Un(Ltd), Charis Thompson, Three Times a Woman- A Gendered Economy of Stem Cell Innovation Pt. 2
This presentation was part of CSW #39;s Life (Un)Ltd project, and took place on October 24, 2012. Life (UnLtd) is an interdisciplinary project initiated by CSW Associate Director Rachel Lee that engages recent developments in biosciences and biotechnology, foregrounding critical, aesthetic, and ethics-based approaches to what have become global research and marketing industries.From:UCLAViews:6 0ratingsTime:36:53More inEducation

Read the original:
Life Un(Ltd), Charis Thompson, Three Times a Woman- A Gendered Economy of Stem Cell Innovation Pt. 2 - Video

Life UnLtd, Charis Thompson, Three Times a Woman A Gendered Economy of Stem Cell Innovation Pt 1
This presentation was part of CSW #39;s Life (Un)Ltd project, and took place on October 24, 2012. Life (UnLtd) is an interdisciplinary project initiated by CSW Associate Director Rachel Lee that engages recent developments in biosciences and biotechnology, foregrounding critical, aesthetic, and ethics-based approaches to what have become global research and marketing industries.From:UCLAViews:6 0ratingsTime:27:24More inEducation

Original post:
Life UnLtd, Charis Thompson, Three Times a Woman A Gendered Economy of Stem Cell Innovation Pt 1 - Video

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/dvn5gf/biotechnology) has announced the addition of the "Biotechnology Market in India" report to their offering.

The Indian biotechnology industry has been growing substantially in the last couple of years. Biotech companies have grown in the country exponentially as a liberalized intellectual property regime and skilled workforce along with low manufacturing costs have boosted the growth of the industry.

With the industry not facing much of the brunt from the global economic recession, the Indian biotechnology industry has been gathering investment and is benefitting from the cost cutting efforts ongoing in many developed countries.

With the diverse flora and fauna that India has, along with the large gene pool and ideal climate, the biotechnology market in India is progressing well, supported by favorable regulations by the Government of India.

Taiyou Research analyzes the potential of the Indian Biotechnology Industry in its research report Biotechnology market in India.

The report covers the following:

- A complete coverage of the global biotechnology market including industry definition, market profile, market statistics, industry performance, market segmentation, competition in the industry, global financing for biotechnology, and a future perspective.

- Moving to the analysis of the biotechnology market in India, we analyze the industry through a market profile, impact of the economic recession on the market, investment in the industry, and biotech companies in India.

- Major tie-ups in the recent years are looked at, along with the issue of Bt Brinjal that rocked the industry recently. The growth of stem cell research and biosimilars is analyzed.

Excerpt from:
Research and Markets: Research Report on the Biotechnology Market in India 2012

blood banks | Umbilical Cord Blood Banking Could Be an Investment in Our Future Health
http://www.cordbloodrecommendation.com Researchers are hopeful that within five years, pieces of the tissue can be used to repair damaged livers and within 15 years, actual liver transplants may be done using lab-grown livers made from cord blood. This is why all of the best companies use the same courier. What is flexing Blood saving?Flex blood caching is a breakthrough in blood caching. As a result, patients can recover faster, thus preventing kidney complications arising from tissue damage. It can be anywhere from about $1500 to about $1800. Following the treatment, David #39;s body created a new blood supply complete with white cells, hence a new immune system. "" Some clinical trials show that the regeneration of the damaged neurons can be done through transplantation of the stem cells in the cord blood. But these are just some diseases from amongst the 70 diseases that can be cured by stem cell, and the list keeps on getting longer. It further saves you from the trouble of locating a matching donor when transplants are concerned. ""Stem cells can be found in multiple locations within our body. -based weekly, that documents breakthrough papers in biotechnology. The umbilical cord is the cord that attaches from the babies belly button to the placenta in the mother #39;s womb during pregnancy. The amount of stem cells is very crucial for any treatment. Private banks on the other hand are for-profit organizations which store blood from the baby for the exclusive use of the donor or donorFrom:loshoteles enmedellinViews:0 0ratingsTime:01:01More inScience Technology

View post:
blood banks | Umbilical Cord Blood Banking Could Be an Investment in Our Future Health - Video

SAN DIEGO, CA--(Marketwire - Nov 7, 2012) - COARE Biotechnology (COARE) and ChemDiv, Inc. (ChemDiv) announced today the formation of a strategic alliance that will offer a fully integrated gene-to-clinic services aimed at development of therapeutic agents that selectively affect cancer stem cells (CSC).

Under terms of this agreement, COARE contributes its pioneering research on the role of Doublecortin-like Kinase 1 (DCLK1) in proliferation and differentiation of CSC including relevant screening reagents and know-how. ChemDiv provides chemistry and biology expertise, including i) small molecule screening libraries, Medicinal Chemistry support, ii) assay adaptation, development and implementation, iii) in vivo testing and iv) advanced preclinical services including DMPK/tox. Dr. Ilya Okun, VP of Biology and CTO at ChemDiv, said: "COARE scientists, have identified a novel enzyme, DCLK1, which plays a key role in development of many solid tumors. This kinase is a promising and tractable target for the discovery of novel specific anti-cancer therapies. I am very excited that the collaboration between ChemDiv and COARE on this program will allow for discovery of new ways to treat a panel of cancers, for which there currently is no effective medicine."

Dr. Courtney W. Houchen, Chief Medical Adviser and cofounder, said, "We are excited at this partnership opportunity and the fact that this collaboration with ChemDiv will bring to the doorstep of both pharmaceutical and biotechnology companies worldwide, our research, expertise and our proprietary assays to help discover small molecules that target, and potentially eradicates or functionally inactivates the most resistant subpopulation of most tumors, the cancer stem cells."

About ChemDiv ChemDiv, Inc. is a Fully Integrated Target-to-Clinic Contract Research Organization (CRO) headquartered in San Diego, CA USA. The company features multiple research and development (R&D) subsidiaries in Russia, Ukraine and China as well as business and logistics operations around the world. We engage pharmaceutical and biotech partners by offering 'one stop' drug discovery and development services based on a project-, FTE- and risk sharing collaborative modes. More information about ChemDiv is available at http://www.chemdiv.com.

About COARE COARE Biotechnology is a research driven biotechnology company dedicated to developing novel anti-cancer therapeutic agents designed to treat solid tumor cancers headquartered in Oklahoma City, OK USA. Our agents are directed against DCLK1, a novel molecular target whose mechanism of action involves multi-pathway, multi-functional cancer inhibition. Recently completed research has shown that this stem cell related protein plays a functional role and is increased in human pancreatic cancer. This protein works to turn off natural tumor suppressors and turns on cancer-causing genes. We are determined to eradicate solid tumor cancers in our lifetime. For additional information about us go to http://www.coarebiotechnology.com

Continue reading here:
Coare Biotechnology and ChemDiv Establish Co-Marketing and Service Collaboration

Donna Dickenson introduces Bioethics
All That Matters author Donna Dickenson introduces the topic covered in her book, Bioethics. Bioethics: All That Matters shows how new departments in biotechnology - like genetics, stem cell research and artificial reproduction - arouse both our greatest hopes and our greatest fears.From:AllThatMattersBooksViews:0 0ratingsTime:01:52More inEducation

The rest is here:
Donna Dickenson introduces Bioethics - Video

NEW YORK, Oct. 30, 2012 /PRNewswire/ -- As many scientists and researchers are aware, biology entails an incredibly complex series of mechanisms and processes that still amaze intelligent minds today. While these biological systems have shaped the world, the application of modern biotechnology has only existed for approximately for three decades. According to a recent FundWeb article, this year marks the 30th anniversary of the "first biotechnology drug approved for human medical use," known as Humulin, "a genetically engineered version of natural human insulin for the treatment of diabetes." Since 1982, biotechnology has seeped its way into modern science and popular applications, which has led many to believe that biotechnology is the next "technology super-cycle." David Lichtenstein, biotechnology supporter and BrainStorm Cell Therapeutics investor, agrees that the science certainly holds the potential to change culture and the way humans live and solve problems.

David Lichtenstein states, "It is amazing to look back at the last 30 years a small period in terms of scientific development and realize just how far biotechnology has come. I expect these applications to become more present in our society, improving every facet of daily life." According to the article, such varied use of biotechnology has been witnessed since the original introduction of Humulin. It states, "Roughly two-thirds of all new drugs approved by the FDA have been discovered and/or developed by a biotechnology company at some stage." In addition to medical use, biotechnology has encouraged significant changes in agriculture and industrial manufacturing."

According to the article, financial analysts believe that biotechnology holds the potential for creating the next major socio-economic era in modern culture. It explains that such possibility for growth opens up a wide variety of investment opportunities in biotechnology. However, few have committed to investing in the science. Having already made significant investments in the field of biotechnology, David Lichtenstein knows that the industry holds promise. At BrainStorm Cell Therapeutics alone, there are projects that focus on repairing ALS, Multiple Sclerosis and Parkinson's disease through stem cell therapy.

David Lichtenstein concludes, "As far as investment strategies go, biotechnology is one field that is new, exciting and offers opportunity for long-term profit. After close examination, I believe wary investors may change their mind about investing in this incredible field of science."

ABOUT:

David Lichtenstein is a supporter of the growth of biotechnology and has become a major investor in the innovative science. He is currently an investor in BrainStorm Cell Therapeutics, a biotechnology company that develops adult stem cell therapies to resolve medical issues associated with severe neurodegenerative disorders including ALS, Multiple Sclerosis and Parkinson's disease. In addition, David Lichtenstein has proven his worth as an investment strategist, having steadily built the Lightstone Group since 1988. As chairman and CEO of the Lightstone Group, David Lichtenstein has carefully developed a diverse portfolio of properties allowing the company to become of the most widespread and successful privately held real estate companies in the United States of America.

See the original post here:
David Lichtenstein: Biotechnology is Rich Area for Investment